Source: ERS Lung Science Conference 2018



Rating:

Share or cite this content

Citations should be made in the following way:
J-W. Shin (Chicago, USA). Mechanical programming of mesenchymal stromal cells to treat lung fibrosis. ERS Lung Science Conference 2018

Member's Comments

No comment yet.

Related content which might interest you: Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury Source: Eur Respir J 2009; 34: 740 Year: 2009 PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: ERS Lung Science Conference 2021 Year: 2021 Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 PP238 – Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis Source: ERS Lung Science Conference 2021 Year: 2021 Identification of mesenchymal stromal cells in lung tissue from lung-transplanted patients Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 Epithelial stem cells at the intersection of tissue regeneration and pulmonary fibrosis Source: Eur Respir Monogr 2021; 91: 290-305 Year: 2021 LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 205-221 Year: 2021 The role of resident lung mesenchymal stromal cells in normal and aberrant lung development Source: Virtual Congress 2020 – Cellular involvement in lung injury Year: 2020 Mesenchymal stem cells and fibrotic lung diseases Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside Year: 2014 Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype Source: Eur Respir Rev 2014; 23: 118-130 Year: 2014 Therapeutic benefits of exosomes derived from mesenchymal stromal cells in bleomycin-induced pulmonary fibrosis in aged mice. Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 The role of epithelial to mesenchymal transition (EMT) in airway remodelling after human lung transplantation Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008 Abnormal proliferation and differentiation of c-kit+ lung stem cells in pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis Source: Eur Respir J 2011; 39: 133-140 Year: 2012 Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 133-140 Year: 2012 Epithelial mesenchymal transition in lung allografts Source: Eur Respir J 2004; 24: Suppl. 48, 180s Year: 2004